← Back to all trials
Not Yet Recruiting
NCT05646537
Stoma Neuro Linguistic Programming Stoma Adaptation Quality of Life
Conditions: Colorectal Cancer
Sex: All
Ages: 18 Years – 85 Years
Phase: NA
Enrollment: 72
Sponsor: Toros University
Summary
The aim of this study is to examine the effect of NLP techniques on stoma compliance and quality of life in patients with stoma.The study will be conducted using a prospective randomized controlled single-blind clinical trial model.The research will consist of patients with temporary or permanent colostomy/ileostomy, who are hospitalized in Mersin City Training and Research Hospital.Research data will be obtained with demographic questionnaire, Adjustment Scale for Individuals with Ostomy and Stoma Quality of Life Scale.Analysis of the study data will be done through the IBM SPSS Statistics 26 package program.
While evaluating the study data, frequencies (number, percentage) for categorical variables and descriptive statistics (mean, standard deviation) for numerical variables will be given.Statistical significance in the analyzes will be interpreted at the 0.05 level.
Eligibility Criteria
Inclusion Criteria:Having opened a stoma for the first time,at least two months and at most 24 months after stoma opening,18 years of age or older,can speak and understand Turkish,can read and write at least,have no disease that may affect their decision-making ability (dementia, psychological disorder, etc.). ) were determined as patients who did not have a disease that could affect their quality of life (other cancers, uncontrolled diabetes, rheumatic diseases, kidney failure, etc.)accepted to participate in the study.Exclusion Criteria:Participants who want to leave voluntarily at any stage after being included in the study, - who cannot communicate verbally,who have hearing or vision problems,who have previously been diagnosed with a psychiatric illness will be excluded from the sample.
Source: ClinicalTrials.gov (NCT05646537). StuddyBuddy aggregates publicly available trial information.